Pulmonx (LUNG) Cash from Financing Activities (2019 - 2025)
Pulmonx (LUNG) reported Cash from Financing Activities of $181000.0 for Q3 2025, down 60.57% year-over-year from $459000.0 in Q3 2024, and up 370.15% quarter-over-quarter from -$67000.0 in Q2 2025.
Pulmonx (LUNG) Cash from Financing Activities (2019 - 2025) Analysis & Trends
Pulmonx (LUNG) has 7 years of Cash from Financing Activities data on file, last reported at $181000.0 in Q3 2025.
- Cash from Financing Activities for Q3 2025 came in at $181000.0, down 60.57% year-over-year; the trailing twelve-month figure through Sep 2025 was $840000.0 (down 36.27% YoY), and the FY2024 annual result was $1.4 million, down 93.63% from the prior year.
- Cash from Financing Activities climbed to $181000.0 in Q3 2025 per LUNG's latest filing, from -$67000.0 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $20.7 million in Q1 2023 and troughed at -$67000.0 in Q2 2025.
- A 5-year average of $1.6 million and a median of $181000.0 in 2025 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2022 and 2025: Cash from Financing Activities jumped 10015.38% in 2022, then slumped 204.55% in 2025.
- A 5-year view of Cash from Financing Activities shows it stood at $150000.0 in 2021, then slumped by 55.33% to $67000.0 in 2022, then sank by 74.63% to $17000.0 in 2023, then soared by 264.71% to $62000.0 in 2024, then surged by 191.94% to $181000.0 in 2025.
- Business Quant data shows LUNG's Cash from Financing Activities at $181000.0 in Q3 2025, -$67000.0 in Q2 2025, and $664000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Pulmonx | 54.38 Mn | -15.37 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 181,000.00 |
| Sep 30, 2025 | 181,000.00 |
| Jun 30, 2025 | -67,000.00 |
| Jun 30, 2025 | -67,000.00 |
| Mar 31, 2025 | 664,000.00 |
| Mar 31, 2025 | 664,000.00 |
| Dec 31, 2024 | 62,000.00 |
| Dec 31, 2024 | 62,000.00 |
| Sep 30, 2024 | 459,000.00 |
| Sep 30, 2024 | 459,000.00 |
| Jun 30, 2024 | -22,000.00 |
| Jun 30, 2024 | -22,000.00 |
| Mar 31, 2024 | 864,000.00 |
| Mar 31, 2024 | 864,000.00 |
| Dec 31, 2023 | 17,000.00 |
| Dec 31, 2023 | 17,000.00 |
| Sep 30, 2023 | 571,000.00 |
| Sep 30, 2023 | 571,000.00 |
| Jun 30, 2023 | 92,000.00 |
| Jun 30, 2023 | 92,000.00 |